CSF CHI3L1 levels of MS patients (age range: 25 to 58) were compared to young healthy controls (age range: <40) and were found to be significantly elevated (p = 0.0007) (Figure 1A, Table 1). This evidence concerns the gene CHI3L1 and myeloid sarcoma.